Falkman L., Sundin A., Skogseid B., Botling J., Bernardo Y., Wallin G., Zhang L., Welin S., Lase I., Mollazadegan K. and Crona J. (2024) “Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors”, Upsala Journal of Medical Sciences, 129(S1), p. e10660. doi: 10.48101/ujms.v129.10660.